Fortress Biotech Inc.

NASDAQ: FBIO · Real-Time Price · USD
2.13
0.17 (8.67%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.47%
After-hours: Aug 15, 2025, 04:10 PM EDT

Fortress Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
57.78M 57.67M 62.5M 82.62M 85.11M 84.51M 80.97M 62.75M 64.25M 75.74M 77.61M 82.17M 81.13M 68.79M 64.26M 52.65M 44.27M
Cost of Revenue
18.85M 20.07M 23.84M 24.99M 26.21M 26.66M 28.36M 29.16M 29.02M 30.77M 32.58M 36.53M 36.38M 32.08M 26.84M 19.05M 14.69M
Gross Profit
38.93M 37.61M 38.66M 57.64M 58.9M 57.85M 52.61M 33.59M 35.23M 44.97M 45.03M 45.64M 44.75M 36.71M 37.42M 33.6M 29.58M
Operating Income
-96.03M -110.28M -106.06M -97.73M -120.04M -142.34M -176.73M -213.04M -213.86M -202.26M -210.26M -210.12M -202.05M -184.8M -147.1M -120.22M -102.76M
Interest Income
2.34M 2.68M 2.86M 2.82M 2.8M 3M 2.98M 2.86M 2.29M 1.4M 855K 568K 564K 649K 795K 928K 1.12M
Pretax Income
-106.12M -120.45M -123.08M -107.03M -137.51M -153.63M -182.03M -224.5M -219.13M -213.46M -224.5M -217.3M -187.76M -164.35M -116.67M -100.78M -104.85M
Net Income
-41.16M -46M -48.51M -40.69M -54.52M -60.64M -78.31M -95.77M -92.35M -86.58M -91.19M -89.46M -71.64M -64.7M -38.43M -33.2M -42.98M
Selling & General & Admin
95.34M 87.62M 83.37M 83.11M 86.72M 94.13M 99.71M 108.12M 112.73M 113.66M 113.16M 105.24M 95.57M 86.84M 74.95M 68.11M 63.19M
Research & Development
35.99M 56.9M 61.03M 71.93M 91.41M 106.07M 127.12M 136.67M 137.66M 134.88M 142.81M 140.99M 141.69M 125.12M 100.03M 85.71M 69.15M
Other Expenses
3.63M 3.38M 320K 320K 814K n/a 2.51M 1.84M -1.3M -1.3M -668K 9.54M 9.54M 9.67M 9.67M 126K 126K
Operating Expenses
134.97M 147.89M 144.72M 155.36M 178.94M 200.2M 229.34M 246.63M 249.08M 247.23M 254.53M 255M 246.04M 220.75M 183.92M 153.22M 131.73M
Interest Expense
13.73M 13.53M 12.99M 9.32M 10.82M 12.52M 15.2M 16.06M 15.59M 13.64M 14.81M 15.86M 15.47M 15.31M 11.58M 14.09M 14.39M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -29.55M -29.55M -29.55M
Cost & Expenses
153.82M 167.96M 168.56M 180.35M 205.16M 226.86M 257.7M 275.78M 278.1M 278M 287.88M 282.75M 273.64M 244.05M 201.82M 172.87M 147.03M
Income Tax Expense
405K 405K 448K 520K 520K 520K 590K -34.99M -34.99M -34.99M -34.97M 473K 473K 473K 136K 136K 136K
Shares Outstanding (Basic)
26.45M 20.24M 19.7M 18.32M 17.15M 7.8M 7.5M 7.38M 6.79M 5.62M 5.96M 5.92M 5.75M 5.58M 5.42M 5.4M 5.39M
Shares Outstanding (Diluted)
26.45M 20.24M 19.7M 18.32M 17.15M 7.8M 7.5M 7.38M 6.79M 6.04M 5.96M 5.92M 5.76M 5.58M 5.42M 5.4M 5.39M
EPS (Basic)
-2.3 -2.85 -3.71 -3.89 -6.81 -9.25 -15.86 -19.03 -19.28 -18.51 -16.37 -16.09 -12.84 -11.78 -7.12 -6.35 -8.61
EPS (Diluted)
-2.3 -2.85 -3.71 -3.89 -6.81 -9.25 -15.86 -19.03 -19.28 -18.51 -16.37 -16.09 -12.84 -11.78 -7.12 -6.35 -8.61
EBITDA
-88.31M -103.16M -108.43M -93.32M -119.57M -133.65M -159.65M -201.55M -198.26M -193.28M -202.34M -194.16M -165.5M -142.85M -104.83M -86.59M -90.87M
EBIT
-93M -107.85M -115.84M -100.16M -126.92M -141.72M -168.61M -210.12M -207.35M -202.66M -210.8M -202.72M -173.61M -150.67M -112.34M -93.97M -97.15M
Depreciation & Amortization
6.83M 6.83M 7.41M 6.84M 7.35M 8.07M 8.96M 8.55M 9.07M 9.35M 8.44M 7.83M 7.38M 6.79M 6.48M 6.08M 5.64M